When vascular reconstructions are complicated by infection or the patient's autologous vasculature is not suitable for use as a conduit, CryoLife provides the treatment option.  Since 1986, more than 4,000 surgeons have implanted over 40,000 vascular allografts to save the lives and limbs of patients throughout the United States and Canada.

Over the years, CryoLife has provided vascular surgeons with multiple options for vascular reconstruction and infection management with the availability of cryopreserved femoral vein and femoral artery, aortoiliac artery and saphenous vein vascular allografts.  CryoLife's cryopreserved vascular conduit alternatives play a vital role as safe and efficient treatment options for vascular reconstructions and infection management.